Samsara BioCapital’s Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third CHFW.U Stock Holding History

Samsara BioCapital’s Portfolio CHFW.U Stock Details CHFW.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-300,000	Closed	-$3.12M	–	51
2021 Q2	$3.12M	Hold	300,000	–	–	0.39%	38
2021 Q1	$2.93M	Hold	300,000	–	–	0.54%	36
2020 Q4	$3.14K	Buy	+300,000	New	+$3.06M	0.32%	32

Samsara BioCapital's CHFW.U Position: Q3 2021 in Review

Samsara BioCapital sold out of Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third (CHFW.U) in Q3 2021, closing a stake of 300,000 shares — an estimated $3.12M sold.

Samsara BioCapital first reported a position in CHFW.U in Q4 2020 and held it in 3 quarters. The position peaked at $3.12M in Q2 2021. 0 funds tracked by Wall St. Rank hold CHFW.U as of Q3 2021.

Samsara BioCapital reported no remaining Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third position as of Q3 2021 after selling out during the quarter.
Samsara BioCapital sold 300,000 Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third shares in Q3 2021, an estimated $3.12M.
Samsara BioCapital first reported a position in Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third in Q4 2020 and held it in 3 quarters.
Samsara BioCapital's Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third position peaked at $3.12M in Q2 2021.
0 funds tracked by Wall St. Rank held Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third as of Q3 2021.

Based on Samsara BioCapital's 13F filing for Q3 2021, filed 15 Nov 2021.